The Enterprise Value as of December 2024 (TTM) for Aptevo Therapeutics Inc. (APVO) is -501422.00

According to Aptevo Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -501422.00. This represents a change of -100.58% compared to the average of 86.48M of the last 4 quarters.

Aptevo Therapeutics Inc. (APVO) Historical Enterprise Value (quarterly & annually)

How has APVO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptevo Therapeutics Inc. over the last ten years is 2.56B. The current -501422.00 Enterprise Value has changed -101.96% with respect to the historical average. Over the past ten years (40 quarters), APVO's Enterprise Value was at its highest in in the March 2015 quarter at 5.99B. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.

Aptevo Therapeutics Inc. (APVO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptevo Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptevo Therapeutics Inc. (APVO) Average Enterprise Value

How has APVO Enterprise Value performed in the past?

The current Enterprise Value of Aptevo Therapeutics Inc. (APVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptevo Therapeutics Inc. (APVO) Enterprise Value vs. Peers

How is APVO’s Enterprise Value compared to its peers?

Aptevo Therapeutics Inc.’s Enterprise Value is less than Kronos Bio, Inc. (8.15M), less than Cyclerion Therapeutics, Inc. (6.04M), less than Larimar Therapeutics, Inc. (211.48M), less than Addex Therapeutics Ltd (7.35M), greater than Achilles Therapeutics plc (-35577954.00), less than Nutriband Inc. (0), less than Quoin Pharmaceuticals, Ltd. (37.65M), greater than Longeveron Inc. (-667131.00), less than RenovoRx, Inc. (4.93M), less than Virax Biolabs Group Limited (21.40M), less than Passage Bio, Inc. (4.10M), less than Magenta Therapeutics, Inc. (33.76M), greater than TRACON Pharmaceuticals, Inc. (-114170976.00), greater than Invivyd, Inc. (-6160275.00), greater than Avenue Therapeutics, Inc. (-44243802.00), less than Hoth Therapeutics, Inc. (935.74K), greater than Revelation Biosciences, Inc. (-2555665.00), greater than NeuroBo Pharmaceuticals, Inc. (-4029924.00), greater than null (-1181216.00),

Build a custom stock screener for Aptevo Therapeutics Inc. (APVO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptevo Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptevo Therapeutics Inc. (APVO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptevo Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.